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Summary Tumour stromal neovascularization was investigated in 114 invasive and 20 in situ carcinomas of the uterine cervix by staining
representative sections with the specific endothelial marker anti CD31 (clone JC/70A, isotope IgG1). A digital image analyser was used to
measure the immunoreactivity. The following parameters were determined in the 'hot spots': vessel counts, vessel perimeter and endothelial
stained area (expressed per mm2). The results were correlated with clinical and histopathological data. There was no significant relationship
between the histopathological findings (tumour histology, tumour differentiation, FIGO stage, presence of lymph node metastasis or lympho-
vascular space involvement) and the median vessel count. In a univariate analysis all angiogenesis parameters had prognostic value: a
higher vascularity was associated with worse prognosis (P< 0.05). Multiple regression analysis showed that vascular permeation (P < 0.001)
and the median vessel count (P = 0.005) were the most important prognostic indicators. In the future these criteria may be used for selection
of patients for anti-angiogenesis therapy.
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The formation of new blood vessels from the existing vascular
network is necessary for tumour growth beyond 2 to 4mm
(Folkman et al, 1989). Because ofthe increased tumour growth and
the extension ofthe vascular network in the tumour, more and more
tumour cells have the opportunity to enter the circulation (Folkman,
1990). Therefore, neovascularization is not only a prerequisite for
expansile growth of solid tumours, but is also correlated with the
potential for metastasis (Weidner et al, 1991).
Tumour angiogenesis is a complex multistep process and arises
from an imbalance between positive and negative angiogenic
stimuli (Folkman and Klagsbrun, 1987). The new capillaries
formed in a malignant tumour are structurally similar to the capil-
laries growing during physiological neovascularization (Folkman
and Klagsbrun, 1987).
Microvessels can be visualized by specifically immunostaining
the endothelial cells. The most sensitive antibody to formalin-
resistant endothelial antigen is the cell surface marker CD31
(Parums et al, 1990; Horak et al, 1992). CD31 is a member of the
adhesion molecule family and is also known as platelet-
endothelial cell adhesion molecule-1 (PECAM-1) or endothelial
cell adhesion molecule (endoCAM-1) (Newman et al, 1990;
Parums et al, 1990). It is a 130- to 120-kDa integral membrane
glycoprotein found on all endothelial cells including capillaries,
sinuses and large vessels, but also in differentiating myelomono-
cytic cells (Newman et al, 1990).
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The relationship between the probability of metastatic disease
and the extent of angiogenesis was first found in cutaneous
melanomas (Srivastava et al, 1988). A later study on breast carci-
nomas showed similar results (Weidner et al, 1991, 1992). Since
then several other studies have followed: e.g. non-small-cell lung
carcinoma (Macchiarini et al, 1992), head-and-neck squamous-
cell carcinoma (Gasparini et al, 1993), prostate (Weidner et al,
1993), bladder carcinoma (Dickinson et al, 1994) and gastric
carcinoma (Meada et al, 1995), all documenting a correlation
between intratumoral microvessel density and increased risk of
metastasis and/or decreased survival. However, not all investiga-
tors have confirmed these results (Fox, 1997). This is probably due
to the different techniques used to quantify the tumour vasculature
(Vermeulen et al, 1996; Fox, 1997).
The present study was performed to investigate the relationship
between the parameters of angiogenesis in a series of cervical
carcinomas with the histopathological features of these tumours
and clinical outcome ofthe patients.
MATERIALS AND METHODS
Patients and follow-up
A total of 114 patients with an invasive cervical carcinoma (mean
age 54 years, range 24-91) and 20 patients with an in situ carci-
noma (mean age 40 years, range 28-62) of the uterine cervix were
studied. The patients were chosen by assessing all available
paraffin-embedded material: only cases with high-quality tissue
preservation, a small amount of necrosis and a considerable
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amount of tumour tissue were incorporated in the study. All
patients were treated between 1979 and 1995 in the Departments
of Obstetrics and Gynaecology of the Antwerp University
Hospital and the General Hospital Saint Camillus-Saint
Augustinus. Sections (5 gm) of formalin-fixed paraffin-embedded
tumour specimens of the most representative tissue block were
used for immunohistochemical staining.
The tumour stage was based on FIGO guidelines (Shepherd,
1996). Twenty (15%) patients had stage 0 disease, 18 (13%) stage
Ia, 37 (28%) stage lb, 32 (24%) stage Ila, nine (7%) stage Ilb, four
(3%) stage Illa, ten (8%) stage IlIb, two (1%) stage IVa and two
(l%) stage IVb. The histological diagnosis, tumour grade,
lympho-vascular space invasion and lymph node status were
determined during routine pathological assessment. Histological
classification of the tumours was based on WHO criteria. Eighty-
eight tumours were squamous-cell carcinomas, 12 adenocarci-
nomas, ten adenosquamous carcinomas and four other types.
Twenty-six (23%O) tumours were well differentiated, 46 (40%)
moderately and 42 (37%) poorly. Twenty-eight per cent of all
invasive carcinomas showed vascular permeation and 37%
lymphatic permeation.
Of the 20 patients with an in situ carcinoma, 12 were treated by
a cone biopsy and eight underwent a hysterectomy. The primary
treatment for 73 patients with early-stage invasive cervical cancer
was a radical hysterectomy according to Wertheim; 35 of them
received post-operative radiotherapy because of positive lymph
nodes and/or lympho-vascular invasion. In 16 patients, a normal
hysterectomy was performed. Twenty of the 114 patients were
primary treated by radiotherapy, four patients received primary
chemotherapy and one patient only had palliative care.
The median follow-up time was 39 months (range 1-203) for
the invasive carcinomas and 31 months (range 11-160) for the in
situ carcinomas. The disease-free and overall survival times were
measured from the date the primary treatment started.
Immunohistochemistry
The 5-jim-thick paraffin sections were deparaffinized and then
treated with 0.3% hydrogen peroxide to block endogenous peroxi-
dase activity. Subsequently, an antigen retrieval procedure for
formalin-fixed paraffin sections was performed by immersion of
the slides in 0.01 citrate buffer (10 mm citrate monohydrate in
distilled water, pH 6.0) and heating in a microwave oven at 700 W
for three times 5 min. After cooling to room temperature, the
slides were incubated for 90 min with CD31 (monoclonal anti-
body, clone JC/70A, isotype IgGI, kappa, M0823, Dako,
Glostrup, Denmark) diluted 1 in 40 in phosphate-buffered saline
(PBS) containing 1% bovine serum albumin (BSA). After three
washes with PBS the slides were incubated with biotinylated
rabbit anti-mouse antibodies (Dako (diluted 1 in 200) for 30 min.
Then they were exposed to strepavidin-biotin-peroxidase
complex (Dako), and diaminobenzidine tetrachloride (DAB)
(Sigma, UK) was used as a chromogen. Counterstaining was
performed with Mayer's haematoxylin. Blood vessels in adjacent
benign tissue served as positive internal control. Negative controls
consisted ofomitting the primary antibody.
Digital image analysis and immunohistochemical
evaluation
All the measurements of CD3 1 immunoreactivity were performed
with a digital image analyser, without knowledge of the patient's
outcome. Digitalization ofthe coloured image was performed with
a microscope (Zeiss, Oberkochen, Germany), a camera (MTI,
USA), and the Vidas 25 software (Kontron, Germany) program
run on a personal computer. The results of discrimination between
vessel and background and some additional processing were
copied as an overlay on to the original coloured image as, because
of variation in staining intensity, the thresholds for discrimination
had to be changed from time to time.
At low magnification (40-100) the slides were scanned for
areas of high vascularization ('hot spots'), based on the criteria of
Weidner et al (1991, 1992) within or adjacent to the invasive
tumour tissue. In patients with an in situ carcinoma, areas just
below the basement membrane were scanned. Within these areas
all vessel measurements were performed at a magnification of250
(field of 0.239 mm2). Any brown-staining endothelial cell or cell
cluster, clearly separated from adjacent microvessels, was consid-
ered as one microvessel. Vessel lumina and red blood cells were
not measured.
Within these 'hot spots' ten random chosen fields were analysed
based on the guidelines from the Gynaecological Cancer
Cooperative Group of the European Organization for Research and
Treatment ofCancer (van Diest et al, 1997). The following parame-
ters were measured: vessel counts, vessel perimeter and endothelial
stained area. The mean number of vessels, the median number of
vessels, the highest number of vessels, the mean number of the
vessel perimeter and the mean number of the endothelial stained
Table 1 Results of measurements of angiogenesis in the invasive carcinoma (n= 114) and in the carcinoma in situ (n = 20) group (t-test)
Median Mean Range P-value
MVC median (vv mm-2) Invasive group 261 287 (11-1000) 0.015
In situ group 146 190 (25-536)
MVC mean (vv mm-2) Invasive group 288 299 (11-955) 0.009
In situ group 164 195 (37-459)
MVC high (vv mm-2) Invasive group 452 467 (17-1180) 0.015
In situ group 305 330 (92-720)
MVP (mm mm-2) Invasive group 15.18 15.71 (0.32-49.45) 0.015
In situ group 8.37 10.23 (0.97-24.45)
EA (%) Invasive group 3.27 3.88 (0.05-10.56) 0.049
In situ group 1.78 2.60 (0.20-7.94)
MVC, microvessel count; MVP, microvessel perimeter, EA, endothelial stained area; w, vessels.
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Table 2 Univariate survival analysis: variables assessed for survival, with
probability values (EGRET analyses only invasive carcinomas)
Age at diagnosis = 0.002 EA = 0.020
FIGO stage < 0.001 MVP = 0.014
Histology = 0.110 MVC mean = 0.008
Tumour grade = 0.021 MVC median = 0.006
Vascular perm < 0.001 MVC high < 0.001
Lymphatic perm < 0.001
LN metastasis = 0.002
EA, endothelial stained area; MVP, microvessel perimetre; MVC, microvessel
count.
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Table 3 Results of a multivariate Cox proportional hazards analysis in
patients with an invasive cervical carcinoma
Variable Coefficient STE P-value
Vasc perm 1.618 (0.384) < 0.001
MVC median 0.293E-02 (0.104E-02) 0.005
Deviance = 240.306; likelihood ratio statistic on 2 d.f. = 23.281 P < 0.001;
STE, standard error.
confounders. The adjusted hazard ratios and their 95% confidence
intervals were calculated by means of a multiple regression
analysis based on the Cox proportional hazard model. For all
statistical analysis a P-value < 0.05 was considered statistically
significant.
RESULTS
A total of three women died from causes other than cervical
cancer, with no evidence of disease, 86 women (64%) were in
complete remission, 45 women (34%) had a recurrence and 40 of
the latter group (30% of the total study group) died from their
tumours.
L I
II 2 Median
I
P= 0.005 Microvessel quantification, histopathological findings
0 50 100 150 200 250 and prognostic relevance
Time (months) The median, mean and range for the microvessel density (median,
The Kaplan-Meier survival curves of 114 patients with an invasive mean and highest), the microvessel perimeter and the percentage
arcinoma with regard to the median microvessel density (log-rank stained endothelial area per mm2 of the invasive and the in situ
).005) group are given in Table 1. The angiogenic parameters in the inva-
sive carcinoma group were all significantly different from those in
the in situ group.
re calculated and expressed per mm2 of stroma and stored Table 2 summarizes the univariate analysis for all the analysed
equent statistical analysis. The groups were divided into histopathological and angiogenic parameters. Out of all the angio-
low with the median as the cut-off value. genic parameters, the highest vessel density has the strongest prog-
)ther investigators we also found a difference of less than nostic value. But it is likely that the highest count is not an optimal
measurement between biopsy or hysterectomy specimen reflection of vessel density.
-he same patient (Bremer et al, 1996). Therefore, we In our study population there was no significant relationship
a biopsy specimen as representative for the stromal frac- between the median vessel count and tumour histology, tumour
he whole tumour. It also enabled us to compare the results differentiation, FIGO stage, presence of lymph node metastases or
tients from which a hysterectomy specimen was available lympho-vascular space involvement.
se from whom only a biopsy specimen was available. The 5-year survival rate for the entire invasive study group was
52% (95% CI 40-64%). The 5-year survival rate for patients with
cal analysis a median vessel density below the median was 63% and for
vessel density above and equal to the median 42% (log-rank test,
tic relevance was based on the analysis of survival time, P < 0.005) (Figure 1).
ias computed from the time of surgery until death (from A Cox proportional hazard regression analysis was then
,e) or date of last follow-up. The associations of all contin- performed in the invasive carcinoma group (Table 3). The best
riables with respect to vascularization and survival were fitting model for overall survival (deviance of 240.306, LR
Iby univariate Cox regression analysis (EGRET). The statistic on 2 d.f. = 23.281, P < 0.001) included vascular perme-
tic indicators were also dichotomized into high and low ation and median vessel count (Table 3). Adding FIGO and/or
- median as cut-off value. Univariate analysis of the tumour differentiation did not lead to a better model or influence
nized indicators was based on the Kaplan-Meier analysis the association between the median vessel density and the prog-
erence between groups (high-low) were tested by a log- nosis. Dividing the median vessel density according to equal and
t. The survival analysis was only performed for the inva- higher or lower than the median value leads to a better under-
tup, not for the in situ group. The presence of potential standing of the observed association. The crude hazard ratio ofthe
ding was assessed by cross-tabulating the studied latter is 2.17 (95% CI 1.15-4.10). Adjustment for vascular perme-
tic indicator with known prognostic indicators. When ation hardly influenced the strength of this association (hazard
ly distributed the known indicators were considered as ratio drops to 1.93).
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DISCUSSION
In this study we investigated tumour angiogenesis as a prognostic
marker in cervical carcinoma by several angiogenic parameters.
There are many markers that can be used to identify the
vascular endothelium: e.g. factor VIII-related antigen, CD34,
vimentin, lectins, alkaline phosphatase, type IV collagen and CD
31 (Fox et al, 1995). Only CD3 1, CD34 and factor VIII-related
antigen are available for staining formalin-fixed endothelial cells
(Fina et al, 1990; Parums et al, 1990; Schlingemann et al, 1990).
Based on a review of the literature we chose JC70, an anti-CD31
antibody, as marker for the microvessels as this endothelial marker
is the most sensitive and specific of all and it does not react with
lymphatic endothelium (Parums et al, 1990; Horak et al, 1992;
Kuzu et al, 1992). However, of the seven previously published
studies about invasive cervical cancer and angiogenesis, six used
factor VIII (Kainz et al, 1995; Rutgers et al, 1995; Schlenger et al,
1995; Wiggens et al, 1995; Dinh et al, 1996; Abulafia et al, 1996),
one Ulex europeaus lectin I (Bremer et al, 1996) and none CD31
as endothelial marker.
Besides the choice of the endothelial cell antibody, the method
of microvessel quantification is of great importance for angiogen-
esis study. In almost all other studies the selection area for tumour
quantification is mainly based on the pioneering work of Weidner
et al (1991, 1992). The latter study stated that it is imperative to
determine the microvessel density in the areas of most intensive
neovascularity ('hot spots'). Like all the previous published
reports about angiogenesis and cervical carcinoma, we analysed
microvessel density in these 'hot spots'.
In five out of the seven studies the vessel counting was
performed manually (Kainz et al, 1995; Rutgers et al, 1995;
Wiggens et al, 1995; Abulafia et al, 1996; Dinh et al, 1996). In the
remaining two studies, the quantification of the tumour vascularity
was performed by a computer. One computer study measured the
distance between the vessels based on the closest-individual
method (DTCMV: distances between random points within the
tumour to the closest microvessel; Schlenger et al, 1995). In doing
so, the distribution of distances from random points within the
tumour to the closest microvessel are determined. The other
computer study measured the morphometry with a quantimet 570
(Bremer et al, 1996). In the present study a digital image analyser
for estimating the tumour angiogenesis was used. The advantage of
computer analysis is that it is objective and therefore may be more
suitable for measuring the tumour angiogenesis in a standardized
way. On the other hand, it is a slow and laborious technique.
In the published studies the amount of fields counted varies
from unknown to 15, the magnification varies from 100 to 400 and
the field size is only mentioned in three studies: 0.216 mm'
(Abulafia et al, 1996), 0.739 mm2 (Dinh et al, 1996) and 0.74 mm2
(Kainz et al, 1995). According to Horak et al (1992) the magnifi-
cation and/or field size influenced only the amount of vessels
counted but not the results. In order to have a representative value
we measured ten randomly chosen fields. The vessel marker,
methodology and the technique used are probably the explanations
for the noticeably higher vessel densities (expressed in mm2) in
our study compared with those in the literature.
Our study showed a significant difference in the results of
measurements of angiogenic parameters between in situ carci-
nomas compared with the invasive carcinomas. These results are
in accordance with the findings of two previously published
studies. The study by Wiggens et al (1995) compared the vessel
density in benign cervical tissue with invasive cervical carcinoma
and showed a higher density in the invasive group (P = 0.013).
Abulafia et al (1996) analysed the microvessel density between
normal cervical epithelium, in situ carcinomas and invasive
cervical carcinoma, and also found a significantly lower
microvessel density in the normal tissue (P < 0.005).
When comparing the results of the seven different studies
published about tumour angiogenesis and cervical carcinoma,
regardless of the methodology, with the present investigation we
found that in five studies the microvessel density was a prognostic
marker in the univariate analysis. In three studies early recurrence
was significantly related with high vessel density (Schlenger et al,
1995; Bremer et al, 1996; Dinh et al, 1996). In our study we found
a similar, but not significant, association. In the current study and
the study by Schlenger et al (1995), a significant relation between
low vessel density and longer overall survival was found. This is
in sharp contrast to the study of Kainz et al (1995), who showed
that high microvessel density predicted longer disease-free
survival. Two studies are without follow-up (Wiggens et al, 1995;
Abulafia et al, 1996) and one study did not find a significant rela-
tionship between tumour vascularization and patient outcome
(Rutgers et al, 1995).
In just two other studies a multiple regression analysis was
performed with a significant association for the microvessel
density. These are also the only two studies that used a computer
for the analysis of the vascularity. The study by Bremer et al
(1996) included as strongest model lymph node status and mean
vessel density. The study by Schlenger et al (1995) included as
strongest model tumour vascularity expressed as mean DTCMV.
Our study had as strongest model median vessel density and
vascular permeation; adding FIGO stage and/or tumour grade did
not lead to a better model. This is probably a particular feature of
our study population because of limited variability of FIGO stage
and tumour grade.
The current study compared different microvessels counts,
percentage of vascular area and vessel perimeter with clinical
outcome in a group ofpatients with a cervical carcinoma. We tried
to determine objectively (standardized measurements) which
parameters were the most accurate for the prognosis ofthe patient.
According to our results the median vessel count is the best angio-
genic parameter, but vascular permeation has the strongest prog-
nostic association. In the future these criteria may be used for
selecting patients for anti-angiogenesis therapy.
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